Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately ...
A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from ...
A new review in Current Cardiology Reviews maps how heart failure management is shifting toward precision medicine—pairing proven therapies (notably SGLT2 inhibitors across the ejection fraction ...
In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...
Analyses identified a high-risk subgroup of patients – described as the ‘lemon-on-sticks’ phenotype – who had a high disease burden and poor outcomes, according to results presented today at Heart ...
Screening for heart failure with an AI-ECG algorithm could be particularly useful in places with limited access to more ...
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart ...
Placebo-controlled evidence across 9013 patients showed a lower composite risk (HR 0.85) driven by reduced worsening HF ...
Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...
Background Introduction of guideline-directed medical therapy (GDMT) has transformed the care of heart failure (HF) with ...
Failure is a predictor of success. This is, without question, one of life's great ironies. And it has deep roots in the evolution of life. And it is, without hesitation, simply true. From a biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results